Glenmede Disciplined U.S. Small Cap Equity Portfolio (GQSCX)
Fund Assets | 2.07M |
Expense Ratio | 0.85% |
Min. Investment | $1,000 |
Turnover | 85.00% |
Dividend (ttm) | 1.49 |
Dividend Yield | 11.08% |
Dividend Growth | 1,851.79% |
Payout Frequency | n/a |
Ex-Dividend Date | Apr 2, 2025 |
Previous Close | 13.46 |
YTD Return | -4.67% |
1-Year Return | 1.01% |
5-Year Return | 81.73% |
52-Week Low | 11.01 |
52-Week High | 17.02 |
Beta (5Y) | 1.06 |
Holdings | 129 |
Inception Date | Nov 13, 2017 |
About GQSCX
The Glenmede Fund, Inc. Quantitative U.S. Small Cap Equity Portfolio is a mutual fund that seeks maximum long-term total return consistent with reasonable risk to principal by investing primarily in U.S. small-cap common stocks. It employs a disciplined, proprietary multi-factor quantitative model for stock selection across various sectors, integrating top-down and bottom-up analysis, downside risk screens, and industry indicators. The portfolio typically holds around 130 stocks from economically U.S.-tied small companies, with a focus on growth and income. Its expense ratio stands at 0.85%, positioning it in the lower cost tier among its peers. The fund's investment strategy balances favorable valuation and risk metrics, aiming to outperform the Russell 2000 Index, a key benchmark for small-cap equities. Its diversified holdings span sectors such as consumer cyclical, technology, healthcare, and industrials, reflecting a comprehensive approach to small-cap equity exposure. Established in 2017, this fund serves investors seeking disciplined, quantitative exposure to the U.S. small-cap equity market segment while maintaining attention to risk management and cost efficiency.
Performance
GQSCX had a total return of 1.01% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.99%.
Top 10 Holdings
14.21% of assetsName | Symbol | Weight |
---|---|---|
Adtalem Global Education Inc. | ATGE | 1.86% |
Verve Therapeutics, Inc. | VERV | 1.60% |
Tutor Perini Corporation | TPC | 1.55% |
Pacira BioSciences, Inc. | PCRX | 1.54% |
CareDx, Inc | CDNA | 1.42% |
Excelerate Energy, Inc. | EE | 1.36% |
Hamilton Insurance Group, Ltd. | HG | 1.23% |
Itron, Inc. | ITRI | 1.22% |
Digi International Inc. | DGII | 1.21% |
EZCORP, Inc. | EZPW | 1.20% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Apr 2, 2025 | $0.0094 | Apr 7, 2025 |
Dec 16, 2024 | $1.4706 | Dec 17, 2024 |
Oct 2, 2024 | $0.0122 | Oct 7, 2024 |
Jul 3, 2024 | $0.038 | Jul 8, 2024 |
Apr 3, 2024 | $0.0059 | Apr 8, 2024 |
Dec 15, 2023 | $0.0258 | Dec 18, 2023 |